mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.2 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |